Florida Health Daily
SEE OTHER BRANDS

Your best source on healthcare and wellness news from Florida

Florida Health Daily: Press Releases

Browse our comprehensive archive of press releases by date.
Select a specific day to access all press releases published on Florida Health Daily.

Press releases published on March 10, 2025

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

Acumen Pharmaceuticals to Participate in Upcoming Investor Conferences

NEWTON, Mass., March 10, 2025 (GLOBE NEWSWIRE) -- Acumen Pharmaceuticals, Inc. (NASDAQ: ABOS), a clinical-stage biopharmaceutical company developing a novel therapeutic that targets toxic soluble amyloid beta oligomers for the treatment of Alzheimer’s …

There Is Hope for American Medicine, Writes President of the Association of American Physicians and Surgeons (AAPS)

There Is Hope for American Medicine, Writes President of the Association of American Physicians and Surgeons (AAPS)

TUSCON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Hope, a very small word with a very large impact, is powerful. Without hope, all is futility, writes Erika L. LeBaron, D.O., M.S.N., in the spring issue of the Journal of American Physicians and Surgeons. “ …

Defenses against Sham Peer Review Discussed in the Journal of American Physicians and Surgeons

Defenses against Sham Peer Review Discussed in the Journal of American Physicians and Surgeons

TUSCON, Ariz. , March 10, 2025 (GLOBE NEWSWIRE) -- False accusations of being a “disruptive physician” can ruin a physician’s career as well as cause moral injury that damages the very core of a physician’s identity, writes Lawrence Huntoon, M.D., Ph.D., …

ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER

ACTG Presents Four Studies at CROI Describing Findings from SLIM LIVER

LOS ANGELES, March 10, 2025 (GLOBE NEWSWIRE) -- ACTG, a global clinical trials network focused on HIV and other infectious diseases, today announced new findings from the SLIM LIVER study (also known as A5371). These data suggest that blood-based …

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025

Immunocore presents initial multiple ascending dose data for HIV functional cure candidate in an oral presentation at CROI 2025 IMC-M113V was well tolerated, with no dose-limiting toxicities Signals of dose-dependent reduction in active reservoir, and …

Long-term Brain Effects from COVID Vaccine Discussed in the Journal of American Physicians and Surgeons

Long-term Brain Effects from COVID Vaccine Discussed in the Journal of American Physicians and Surgeons

TUCSON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- Rushed into production, the mRNA COVID vaccine was administered to 100 million people too soon to see any possible long-term neurologic effects, particularly in babies of mothers vaccinated during pregnancy …

Mental Health and the COVID Vaccine Discussed in the Journal of American Physicians and Surgeons

Mental Health and the COVID Vaccine Discussed in the Journal of American Physicians and Surgeons

TUCSON, Ariz., March 10, 2025 (GLOBE NEWSWIRE) -- In the wake of the COVID pandemic, many persons suffered severe mental health problems, which could have resulted from many causes, writes Jane Orient, M.D., in the spring issue of the Journal of American …

Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025

Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025

ORION CORPORATION STOCK EXCHANGE RELEASE – CHANGES IN COMPANY’S OWN SHARES 10 MARCH 2025 at 19.00 EET            Orion Corporation: Transfer of 191,911 own B shares on 10 March 2025 In accordance with a decision by the Board of Directors, Orion Corporation …

Orion Oyj: 191 911 oman B-osakkeen luovutus 10.3.2025

Orion Oyj: 191 911 oman B-osakkeen luovutus 10.3.2025

ORION OYJ                 PÖRSSITIEDOTE – MUUTOKSET OMIEN OSAKKEIDEN OMISTUKSESSA         10.3.2025 KLO 19.00          Orion Oyj: 191 911 oman B-osakkeen luovutus 10.3.2025 Orion Oyj:n hallituksen päätöksen mukaisesti Orion Oyj on 10.3.2025 luovuttanut …

Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO

Tevogen Bio Announces Unique T Cell Vaccine Under Development and Files Patent with the USPTO

Vaccine is intended to stimulate T cell responses against targets across the entire genome of the selected virus, similar to company’s lead product candidate TVGN 489, to mitigate the risk posed by mutations. Approach may provide prophylaxis to viral …

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board

Psyence Group's NASDAQ-Listed Associate, Psyence Biomedical, names Albert P. Garcia-Romeu, Ph.D. as Chair of its Newly Created Scientific Advisory Board

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- Psyence Group Inc ("Psyence Group" or the "Company") (CSE: PSYG) is pleased that its NASDAQ-listed associate, Psyence Biomedical Ltd (NASDAQ: PBM) ("PBM" or "Psyence Biomed"), has announced that it will work …

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.)

ORION OYJ         PÖRSSITIEDOTE / SUURIMMAT OSAKKEENOMISTAJAT -TIEDOTE         10.3.2025 KLO 17.00          Orion Oyj: Arvopaperimarkkinalain 9. luvun 10. pykälän mukainen ilmoitus (BlackRock, Inc.) Orion Oyj on saanut Arvopaperimarkkinalain 9. luvun 5 §:n …

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

Smith+Nephew to highlight breakthrough Sports Medicine technologies for joint repair at AAOS 2025

Smith+Nephew (LSE:SN, NYSE:SNN), the global medical technology company, today announces it will showcase the latest advancements in Sports Medicine for joint repair at the American Academy of Orthopaedic Surgeons Annual Meeting in San Diego this week. Some …

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.)

ORION CORPORATION STOCK EXCHANGE RELEASE / MAJOR SHAREHOLDER ANNOUNCEMENTS 10 March 2025 at 17.00 EET          Orion Corporation: Disclosure Under Chapter 9 Section 10 of the Securities Market Act (BlackRock, Inc.) Orion Corporation has received a …

Teen Girls Meet Georgia Legislators at Pace Day at the Capitol

Teen Girls Meet Georgia Legislators at Pace Day at the Capitol

Atlanta, Georgia, March 10, 2025 (GLOBE NEWSWIRE) -- Pace Center for Girls (Pace), a nationally recognized model that provides education, counseling, training and advocacy for girls and young women, hosted its annual Pace Day at the Capitol event in …

Chopped Leaf Ignites Taste Buds with New Jalapeño Popper Grilled Cheese

Chopped Leaf Ignites Taste Buds with New Jalapeño Popper Grilled Cheese

Oakville, Ontario, Canada, March 10, 2025 (GLOBE NEWSWIRE) -- March 10, 2025 (Oakville, ON) – Chopped Leaf is turning up the heat in the sandwich category with the launch of its newest menu item: the Jalapeño Popper Grilled Cheese. Available for a limited …

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Genmab Announces Johnson & Johnson Decision Regarding HexaBody®-CD38

Company Announcement Johnson …

First Patient Enrolled in Merit Medical’s PREEMIE Study

First Patient Enrolled in Merit Medical’s PREEMIE Study

SOUTH JORDAN, Utah, March 10, 2025 (GLOBE NEWSWIRE) -- Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced enrollment of the first patient in its multicenter, prospective study of the Bloom Micro Occluder …

PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands

PharmAla Signs Duchefa Farma as Exclusive Distributor in Netherlands

TORONTO, March 10, 2025 (GLOBE NEWSWIRE) -- PharmAla Biotech Holdings Inc. (“PharmAla” or the “Company”) (CSE: MDMA) (OTC:MDXXF), a biotechnology company focused on the research, development, and manufacturing of novel MDXX class molecules (including its …

BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System

BioCardia Announces Japanese Patent for Helix™ Biotherapeutic Delivery System

SUNNYVALE, Calif., March 10, 2025 (GLOBE NEWSWIRE) -- BioCardia®, Inc. [Nasdaq: BCDA], a global leader in cellular and cell-derived therapeutics for the treatment of cardiovascular and pulmonary diseases, today announces that the Japan Patent Office has …

Share us

on your social networks:
AGPs

Get the latest news on this topic.

SIGN UP FOR FREE TODAY

No Thanks

By signing to this email alert, you
agree to our Terms of Service